Sensus Healthcare, Inc. (SRTS) Gross Margin
- Gross margin · 12 months: Value 36.39%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 36.39% | Gross profit / revenue. Period ending 2026-06-30. $6.37M ÷ $17.51M × 100 ≈ 36.39% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 6.37M USD | Gross Profit |
| Revenue | 17.51M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 11.14M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $6.37M | $17.51M | $11.14M | 36.39% |
| 2026-03-31 | $8.50M | $22.53M | $14.03M | 37.74% |
| 2025-12-31 | $11.87M | $27.48M | $15.62M | 43.18% |
| 2025-09-30 | $17.08M | $35.61M | $18.53M | 47.95% |
| 2025-06-30 | $19.60M | $37.56M | $17.96M | 52.18% |
| 2025-03-31 | $22.12M | $39.49M | $17.36M | 56.02% |
| 2024-12-31 | $24.43M | $41.81M | $17.38M | 58.44% |
| 2024-09-30 | $25.16M | $41.31M | (m) | 60.90% |
| 2024-06-30 | $21.90M | $36.37M | (m) | 60.23% |
| 2024-03-31 | $19.10M | $31.65M | $12.55M | 60.34% |
| 2023-12-31 | $14.06M | $24.41M | $10.35M | 57.61% |
| 2023-09-30 | $14.58M | $24.94M | $10.36M | 58.45% |
| 2023-06-30 | $18.46M | $30.06M | $11.59M | 61.44% |
| 2023-03-31 | $24.10M | $37.61M | $13.51M | 64.08% |
| 2022-12-31 | $29.63M | $44.53M | $14.90M | 66.53% |
| 2022-09-30 | $30.13M | $44.45M | $14.32M | 67.79% |
| 2022-06-30 | $27.46M | $40.97M | $13.51M | 67.03% |
| 2022-03-31 | $22.55M | $34.31M | $11.76M | 65.73% |
| 2021-12-31 | $16.99M | $27.04M | $10.05M | 62.82% |
| 2021-09-30 | $11.36M | $19.11M | $7.75M | 59.44% |
| 2021-06-30 | $8.83M | $15.21M | $6.37M | 58.08% |
| 2021-03-31 | $6.13M | $10.97M | $4.84M | 55.85% |
| 2020-12-31 | $5.25M | $9.58M | $4.33M | 54.81% |
| 2020-09-30 | $7.48M | $12.99M | $5.51M | 57.56% |
| 2020-06-30 | $10.65M | $17.21M | $6.56M | 61.87% |
| 2020-03-31 | $14.95M | $23.51M | $8.56M | 63.60% |
| 2019-12-31 | $17.56M | $27.26M | $9.71M | 64.40% |
| 2019-09-30 | $16.96M | $26.83M | $9.87M | 63.20% |
| 2019-06-30 | $17.29M | $27.33M | $10.04M | 63.25% |
| 2019-03-31 | $16.29M | $25.91M | $9.62M | 62.86% |
| 2018-12-31 | $16.91M | $26.43M | $9.52M | 63.99% |
| 2018-09-30 | $16.36M | $24.82M | $8.45M | 65.94% |
| 2018-06-30 | $15.41M | $23.28M | $7.87M | 66.21% |
| 2018-03-31 | $14.89M | $22.19M | $7.30M | 67.09% |
| 2017-12-31 | $13.80M | $20.59M | $6.79M | 67.03% |
| 2017-09-30 | $12.83M | $19.00M | $6.17M | 67.54% |
| 2017-06-30 | $11.86M | $17.53M | $5.67M | 67.67% |
| 2017-03-31 | $10.77M | $16.13M | $5.36M | 66.75% |
| 2016-12-31 | $9.85M | $14.81M | $4.97M | 66.48% |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | $6.58M | $10.27M | $3.69M | 64.05% |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |